Tumour burden is an independent prognostic factor in metastatic renal cell carcinoma. [electronic resource]
Producer: 20130208Description: 1747-53 p. digitalISSN:- 1464-410X
- Aged
- Angiogenesis Inhibitors -- administration & dosage
- Antineoplastic Agents -- administration & dosage
- Benzenesulfonates -- administration & dosage
- Carcinoma, Renal Cell -- drug therapy
- Disease-Free Survival
- Female
- Humans
- Indoles -- administration & dosage
- Kidney Neoplasms -- drug therapy
- Male
- Middle Aged
- Niacinamide -- analogs & derivatives
- Phenylurea Compounds
- Prospective Studies
- Pyridines -- administration & dosage
- Pyrroles -- administration & dosage
- Sorafenib
- Sunitinib
- Treatment Outcome
- Tumor Burden -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.